A robust fixed point transformation-based approach for type 1 diabetes control

Abstract

Modeling and control of diabetes mellitus (DM) are difficult due to the highly nonlinear attitude, time-delay effects, the impulse kind input signals and the lack of continuously available blood glucose (BG) level to be regulated. Regarding the mentioned problems, identification of DM model is crucial. Furthermore, due to the lack of information about the internal states (which cannot be measured in everyday life) and because the BG level is not available in every moment over time, adaptive robust control design method regardless exact model dependency would successfully handle these unfavorable effects without simplifications. The recently developed nonlinear robust fixed point transformation (RFPT)-based controller design method requires only a roughly approximate model in order to realize the controller structure. Moreover, parallel simulated approximate models-in order to provide additional internal information-can be used with the method. In this paper, the usability of the novel RFPT-based technique is demonstrated on the physiological problem of diabetes.

Gain-Scheduling Control Solutions for Magnetic Levitation Systems

“…Seven control solutions with PI controllers have been designed using the pole-zero cancellation method [52] depending on the operating points and on the transfer functions (8). The expressions of the t.f.s of the designed PI controllers are rewritten as [52,[54][55][56]…”

Nonlinear Model Predictive Control Using Robust Fixed Point Transformation-Based Phenomena for Controlling Tumor Growth

“…in which ∆t is the time step of the discretization. In (2), the left side of the prediction corresponds to the state variables in (3), namely…”

“…In the past decades, physiological systems gained attention among control engineers. This particular interest covers a significant variety of topics including automated anesthesia [1], diabetes control [2] and hormonal regulation [3]. Tumor growth control is no exception as cancerous diseases are responsible for 1,359,500 deaths in the European Union annually, based on [4].…”

Tensor Product Model Transformation-based Parallel Distributed Control of Tumor Growth

“…Similarly to other physiological control applications like diabetes or anesthesia [8][9][10][11][12][13] the control of tumor growth is challenging due to several unfavorable effects that should be taken into account. The nonlinear nature of the process completed with cross-effects, parameter and model uncertainties and time-delays increases the difficulty of the problem.…”